A 23-year-old Louisiana resident has become the first person in the U.S. Gulf Coast region to be functionally cured of sickle cell disease through groundbreaking gene-editing therapy, offering renewed hope for millions of people living with the inherited blood disorder worldwide.
According to The Guardian, Daniel Cressy, from Metairie, Louisiana, achieved the milestone after completing a two-year treatment programme at Manning Family Children’s Hospital in New Orleans using the CRISPR/Cas9 gene-editing technology marketed as Casgevy. The treatment effectively eliminated the disease’s symptoms by modifying his own stem cells to produce healthy red blood cells.
Diagnosed with sickle cell disease in infancy, Cressy endured years of chronic pain, frequent hospitalisations and health complications associated with the genetic disorder. His dream of becoming a commercial airline pilot was also put on hold after the U.S. Federal Aviation Administration (FAA) declined to certify him because of the medical risks posed by sickle cell disease at high altitudes.
Determined to pursue his aviation career, Cressy opted for the pioneering gene-editing treatment after learning that a cure could make him eligible for medical certification. The process began with doctors collecting his stem cells, which were sent to a laboratory in Scotland for genetic modification. Following chemotherapy to eliminate the defective blood-forming cells, the edited stem cells were infused back into his body, enabling him to produce healthy blood cells.
After a month of inpatient recovery and monitoring, doctors declared Cressy functionally cured of the disease. During a ceremonial bell-ringing celebration attended by family, medical staff and public officials, he described the experience as the beginning of a new life. “While many spend their lives searching for purpose, mine found me. Now, instead of looking for meaning, I can spend my life fulfilling it,” Cressy said.
Hospital officials hailed the achievement as a transformational moment for patients living with sickle cell disease. Lucio Fragoso, Chief Executive Officer of Manning Family Children’s Hospital, said the successful treatment demonstrates how curative gene therapy is restoring futures and providing fresh hope for families affected by the condition. Looking ahead, Cressy plans to resume his pursuit of a commercial pilot’s licence, write a book titled Blessing in the Skies, and expand his nonprofit organisation, the Privileged Pilots Project, which aims to improve access to healthcare, aviation opportunities and support for people facing medical, economic and social challenges.
